Results 171 to 180 of about 3,329,022 (392)

Incomes and inequality in the long run: the case of German elderly [PDF]

We employ German Sample Survey Income data to examine income inequality and the financial situation of elderly citizens for the period from 1978 to 2003, focussing on differences between retired and non-retired elderly and between elderly with residence ...
Bönke, Timm, Schröder, Carsten, Schulte, Katharina   +2 more
core  

The Usefulness of Activity Trackers in Elderly with Reduced Mobility: A Case Study [PDF]

, 2013
This study was conducted to determine the accuracy and usefulness of two current commercially available activity trackers in rollator dependent elderly with reduced mobility (RME), compared with elderly with normal mobility (NME) and healthy adults ...
Civit Balcells, Antón, Lauritzen, Jonas, Muñoz Macho, Adolfo, Sevillano Ramos, José Luis   +3 more
core  

EGFR‐STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1‐positive prostate cancer

Molecular Oncology, EarlyView.
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva, Bernardo Orr, Ana Azeredo, Andreia Brandão, Manuel R. Teixeira, Paula Paulo   +5 more
wiley   +1 more source

Comparison of mortality rates in elderly hypertensive and normotensive hemiplegic patients. [PDF]

, 1966
J. D. Merrett, Gerry Adams
openalex   +1 more source

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

Molecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon, Moa Stenudd, Margherita Zamboni, Kanar Alkass, Carl‐Johan Eriksson, Lars Pedersen, Alrik Schörling, Anna Thoss, Anders Bergh, Pernilla Wikström, Hans‐Olov Adami, Henrik Toft Sørensen, Henrik Druid, Jonas Frisén   +13 more
wiley   +1 more source

REPORT TO THE LANG CLINICAL RESEARCH COMMITTEE, ROYAL LONDON OPHTHALMIC HOSPITAL: A BILATERAL CHRONIC AFFECTION OF THE ENDOTHELIAL FACE OF THE CORNEA OF ELDERLY PERSONS WITH AN ACCOUNT OF THE TECHNICAL AND CLINICAL PRINCIPLES OF ITS SLIT-LAMP OBSERVATION

, 1924
Barbara J. Graves
openalex   +1 more source

Relating Health and Social Contacts to the Morale of Elderly Persons [PDF]

, 1969
Ilse J. Volinn, Jess B. Spielholz
openalex   +1 more source

Association of high‐dose radioactive iodine therapy with PPM1D‐mutated clonal hematopoiesis in older individuals

Molecular Oncology, EarlyView.
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim, Sungwoo Bae, Jaeyong Choi, Sun‐Wha Im, Bukyoung Cha, Gyeongseo Jung, Sun Wook Cho, Eul‐Ju Seo, Young Ah Lee, Jin Chul Paeng, Young Joo Park, Jong‐Il Kim   +11 more
wiley   +1 more source

Frailty in elderly people

The Lancet, 2013
A. Clegg, John B. Young, S. Iliffe, M. Rikkert, K. Rockwood   +4 more
semanticscholar   +1 more source

Commentary: AI-based online chat and the future of oncology care: a promising technology or a solution in search of a problem?

Frontiers in Oncology, 2023
Hui Zhang, Yongfu Guan, Jinping Chen, Wenting Tong   +3 more
doaj   +1 more source